Progressive brain changes in schizophrenia

Schizophrenia Bulletin

Volumn 34, Issue 2, 2008, Pages 310-311

  Arango, Celso ^a   Kahn, René ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DYSFUNCTION; DISEASE COURSE; EDITORIAL; ENVIRONMENTAL FACTOR; GENETIC RISK; HEREDITY; HUMAN; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SCHIZOPHRENIA;

BRAIN; DISEASE PROGRESSION; HUMANS; SCHIZOPHRENIA;

EID: 40049109824     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm166     Document Type: Editorial

References (10)

1. Woods BT. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry. 1998;155:1661-1670.
2. Woods BT, Yurgelun-Todd D, Goldstein JM, Seidman LJ, Tsuang MT. MRI brain abnormalities in chronic schizophrenia: one process or more? Biol Psychiatry. 1996;40:585-596.
3. Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. Mapping cortical change across the human life span. Nat Neurosci. 2003;6:309-315.
4. Cannon TD, Huttunen MO, Dahlstrom M, Larmo I, Rasanen P, Juriloo A. Antipsychotic drug treatment in the prodromal phase of schizophrenia. Am J Psychiatry. 2002;159:1230-1232.
5. Weinberger DR, McClure RK. Neurotoxicity, neuroplasticity, and magnetic resonance imaging morphometry: what is happening in the schizophrenic brain? Arch Gen Psychiatry. 2002;59:553-558.
6. Lieberman JA, Tollefson GD, Charles C, et al. Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry. 2005;62:361-370.
7. Salisbury DF, Kuroki N, Kasai K, Shenton ME, McCarley RW. Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia. Arch Gen Psychiatry. 2007;64:521-529.
8. Rapoport JL, Addington AM, Frangou S, Psych MR. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry. 2005;10:434-449.
9. Rapoport JL, Gogtay N. Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging. Neuropsychopharmacology. 2008;33:181-197.
10. Whitford TJ, Grieve SM, Farrow TF, et al. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study. Neuroimage. 2006;32:511-519.